F
Fulcrum Therapeutics D
D
FULC
6.44000
USD
0.31
(5.06%)
مغلق
حجم التداول
29,757
الربح لكل سهم
-1
العائد الربحي
-
P/E
-644
حجم السوق
347,626,731
الأخبار المقالات
العنوان: Fulcrum Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.